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Abstract:
Introduction: Necrotizing fasciitis (NF) is a life-threatening illness, particularly when surgical
debridement is delayed. The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score
was developed to identify patients at higher risk for NF. Despite limited information in this regard,
the LRINEC score is often used to “rule out” NF if negative. We describe the sensitivity of the
LRINEC score in emergency department (ED) patients for the diagnosis of NF.
Methods: We conducted a chart review of ED patients in whom coding of hospital discharge
diagnoses included NF. We employed standard methods to minimize bias. We used laboratory
data to calculate the LRINEC score, and confirmed the diagnosis of NF via explicit chart review.
We then calculated the sensitivity of a positive LRINEC score (standardly defined as six or greater)
in our cohort. We examined the role of patient characteristics in the performance of the LRINEC
score. Finally, we performed sensitivity analyses to estimate whether missing data for c-reactive
protein (CRP) results were likely to impact our results.
Results: Of 266 ED patients coded as having a discharge diagnosis of NF, we were able to confirm
the diagnosis, by chart review, in 167. We were able to calculate a LRINEC score in only 80
patients (due to absence of an initial CRP value); an LRINEC score of 6 or greater had a sensitivity
of 77%. Sensitivity analyses of missing data supported our finding of inadequate sensitivity to rule
out NF. In sub-analysis, NF patients with concurrent diabetes were more likely to be accurately
categorized by the LRINEC score.
Conclusion: Used in isolation, the LRINEC score is not sufficiently sensitive to rule out NF in a
general ED population.
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Introduction: Necrotizing fasciitis (NF) is a life-threatening illness, particularly when surgical
debridement is delayed. The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score was
developed to identify patients at higher risk for NF. Despite limited information in this regard, the
LRINEC score is often used to “rule out” NF if negative. We describe the sensitivity of the LRINEC
score in emergency department (ED) patients for the diagnosis of NF.
Methods: We conducted a chart review of ED patients in whom coding of hospital discharge
diagnoses included NF. We employed standard methods to minimize bias. We used laboratory data
to calculate the LRINEC score, and confirmed the diagnosis of NF via explicit chart review. We then
calculated the sensitivity of a positive LRINEC score (standardly defined as six or greater) in our
cohort. We examined the role of patient characteristics in the performance of the LRINEC score.
Finally, we performed sensitivity analyses to estimate whether missing data for c-reactive protein
(CRP) results were likely to impact our results.
Results: Of 266 ED patients coded as having a discharge diagnosis of NF, we were able to confirm
the diagnosis, by chart review, in 167. We were able to calculate a LRINEC score in only 80 patients
(due to absence of an initial CRP value); an LRINEC score of 6 or greater had a sensitivity of 77%.
Sensitivity analyses of missing data supported our finding of inadequate sensitivity to rule out NF. In
sub-analysis, NF patients with concurrent diabetes were more likely to be accurately categorized by
the LRINEC score.
Conclusion: Used in isolation, the LRINEC score is not sufficiently sensitive to rule out NF in a
general ED population. [West J Emerg Med. 2016;17(3):333–336.]

INTRODUCTION
Necrotizing fasciitis (NF) is a life-threatening infection
with high mortality. Because NF can be misdiagnosed as
a less lethal mimic, such as cellulitis and abscess, efforts
have been made to identify clinical features that could help
clinicians accurately diagnose NF and avoid delays to surgical
debridement.1 Prior retrospective studies have shown certain
Volume XVII, no. 3 : May 2016

laboratory values, particularly an extremely elevated leukocyte
count and a low sodium concentration, are associated with
NF.2 These abnormal values might help clinicians distinguish
NF from less severe soft-tissue infections. The Laboratory
Risk Indicator for Necrotizing Fasciitis (LRINEC) score was
developed in a large cohort of admitted patients to identify
patients at higher risk for NF.3 Patients are assigned a LRINEC
333
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score based on serum sodium, glucose, creatinine, c-reactive
protein (CRP), leukocyte count and hemoglobin. Scores range
from 0 to 13; a score 6 or greater was associated with a high
risk of NF, and a score of 8 or greater with a very high risk.
The LRINEC score can be easily misapplied, however.
The score was not designed to exclude NF in patients
with a low-risk score, and case reports and small studies
externally validating the score failed to replicate the high
sensitivity and negative predictive value reported in the
initial paper.4-8 Additionally, the sensitivity of the score
has not been addressed specifically among emergency
department (ED) patients.
We conducted this retrospective study to determine
the sensitivity of the LRINEC score in ED patients with a
confirmed diagnosis of NF and examine the role of patient
factors in the score’s sensitivity. We also performed secondary
analyses to estimate how missing laboratory values impacted
our results.

met, were classified as “unconfirmed” and were excluded.
LRINEC Scores
During laboratory value review, abstractors were blinded
to the final “confirmation” of NF in any individual case.
Only the first value for each laboratory test was collected,
eliminating conflicting data. Abstractors coded a result
as “missing” if there was no result in the first 48 hours of
the hospital course; this occurred only with CRP; all other
laboratory tests were present for every patient. These cases
were excluded as no score could be calculated.
Patient Characteristics
Patient age, gender and inpatient mortality were collected
from administrative data. Past medical history was abstracted
from medical history and final diagnoses on operative reports,
discharge summaries and death notes.

Primary Study: Sensitivity of the LRINEC Score in ED
Patients
Chart Abstraction Methods
We used standard abstraction methods to minimize bias.9
All abstractors received training. Medical students blinded
to the study hypothesis calculated the LRINEC score after
two training sessions; the lead author also reviewed their first
results to ensure reliability and accuracy, and a coding guide
was made available to abstractors (Appendix 1). The lead
author reviewed 10% of cases, and with a Kappa calculated
for abstracted variables.
Diagnosis Confirmation
The ICD-9 diagnosis of NF was confirmed if any of the
following criteria were met: 1) NF was a diagnosis on the hospital
discharge or death summary; 2) NF was confirmed at surgery,
as documented by operative report; or 3) fascial necrosis was
documented on an anatomic pathology specimen. Patients with
ICD-9 coding of “NF” but in whom none of these criteria were
Western Journal of Emergency Medicine

Primary Study: Sensitivity of LRINEC score, and
Association with Patient Factors
A LRINEC score was calculated for each patient (Figure),
and the overall sensitivity of the score was calculated using
STATA version13, with a binomial model for confidence
intervals. We included only patients with complete data. We
used chi-squared tests and t-tests to examine the sensitivity of
the LRINEC score when stratifying by patient factors of age,
gender, inpatient mortality and history of cirrhosis, intravenous
drug use or diabetes, known risk factors for developing NF.
Secondary Study: Analysis of Missing Data
All cases without laboratory results to calculate a
LRINEC score were missing a CRP, so we performed
sensitivity analyses to determine how this impacted our
results. We calculated a LRINEC score for each patient
with missing data based on the assumption that the missing
CRP value “would have been” positive in 50%, 77% (the
sensitivity of the LRINEC score found in our cohort), or
100% of cases. Because of the large contribution of CRP
to the LRINEC score, we assumed that if the CRP was
positive, the LRINEC score would also be positive. We

LRINEC Score

METHODS
The study was approved by the institutional review board
prior to initiation.
The study cohort consisted of patients evaluated in the
ED of Los Angeles County+University of Southern California
Medical Center (LAC+USC) with NF. The LAC+USC
ED is an urban, academic, tertiary care hospital. Patients
were identified by search of all International Statistical
Classification of Diseases and Related Health Problems, Ninth
Revision (ICD-9) hospital discharge codes between April
2003 and April 2013; charts of all patients coded as having NF
(728.86) were then reviewed, and further categorized as either
“confirmed” or “unconfirmed” (see below.) Patients who were
not initially evaluated in the ED or who developed NF postoperatively after admission were excluded.
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Figure. Count of cases at each Laboratory Risk Indicator for
Necrotizing Fasciitis (LRINEC) score.
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calculated the sensitivity of the score under at each of these
assumptions for CRP.
RESULTS
Primary Study
A computerized records search identified 316 patients
between April 2003 and April 2013 with ICD-9 discharge
diagnosis of NF. We excluded 47 cases that were not admitted
through the ED and three cases that developed NF in the
post-operative period while inpatient. NF was “confirmed”
by chart review in 167 cases, with 100% interrater agreement
(Kappa=1.0), but only 80 of these patients had a CRP
documented in the first 48 hours of presentation. The interrater
reliability for a positive LRINEC score was excellent
(Kappa=0.91), as was that for history of diabetes (K=0.84).
Interrater reliability for history of cirrhosis and intravenous
drug use was good (K=0.78 for both). Demographic
characteristics and percentage of cases with each LRINEC
score are shown in Table.
In the final study cohort, the overall sensitivity of
the LRINEC score was 77% (CI [66-85]). Patients with
diabetes were more correctly categorized by the score than
patients without diabetes (85% vs 67%, p=0.04). There was
no difference in the score’s sensitivity when patients were
stratified by age, gender, inpatient mortality nor history of
cirrhosis or intravenous drug use.
Secondary Analyses
If the CRP and resultant LRINEC score are assumed
to be “positive” in 50%, 77% or 100% of cases missing
data, the sensitivity would be 63% (CI [55-70]), 76% (CI
[69-82]) or 89% (CI [83-93]), respectively. Our analysis of
missing data gives a range of sensitivities of as low as 55%
to as high as 93%.
DISCUSSION
In our population of ED patients with NF, the LRINEC
score had a measured sensitivity of 77%, substantially
lower than the 91% reported by Wong.3 Our population
differs from the Wong cohort in that our patients came
exclusively from the ED and were younger, more
frequently male and had a higher mortality rate. Our
finding that the LRINEC score, applied in isolation, would
miss over 20% of cases of NF is consistent with reports of
sensitivities between 68% and 80% in smaller studies based
in surgical referral centers.6-8,10
While our sensitivity analyses, based on realistic
possibilities regarding missing CRP data, suggest that
the sensitivity of the LRINEC score could range between
55% and 93%, it is likely that the true value is less than
80%. Our calculated sensitivity for LRINEC may be
artificially high, since in clinical practice this score is often
used to decide whether a patient needs further work up
or surgical management. Patients with NF and a falsely
Volume XVII, no. 3 : May 2016

negative LRINEC score are less likely to have the diagnosis
confirmed through pathologic specimens (and would be
missed by our study methodology).
LIMITATIONS
The focus of this study is the sensitivity of the LRINEC
score in ED patients of one hospital; the findings may have
limited generalizability. The use of a single ICD-9 code
may miss cases of NF due to miscoding. The validity of any
chart review is threatened to the extent that it relies on data
that is frequently missing, internally inconsistent, and/or
poorly gathered. To minimize this, we employed standard
retrospective chart review methodology. Reviewers were
trained and were largely blinded to our study hypothesis
and outcome data. We conducted duplicate review to assess
reliability, used precise definition of both independent and
dependent variables, and relied on only initial laboratory
data to decrease inconsistency. We minimized issues
with missing data, except with regard to CRP. To address
the high number of missing CRP values, we performed
sensitivity analyses covering reasonable assumptions about
how the missing values might have affected our results.
As no possible values for the missing data could have
produced a high sensitivity of the LRINEC, our primary
conclusion – that a normal LRINEC score should not
by itself be used to rule out NF – remains qualitatively
unchallenged regardless of what these missing CRP values
might have been. Additionally, it is possible that spectrum
bias is present, and that the LRINEC score performs better
in the most severe cases; however, an ideal diagnostic
adjunct would aid a clinician in identifying the correct
diagnosis in subtle cases.
CONCLUSION
In this cohort, the LRINEC score with the standard
cut-off of six would miss over 20% of cases of NF. Our
results suggest that clinicians must maintain a high index of

Table. Characteristics of patients with confirmed necrotizing fasciitis.
n=81
%
Male

80%

Inpatient mortality

35%

Age (mean, SD)

47.5 (1.4)

History of diabetes

49%

History IVDU

18%

History of cirrhosis

6%

LRINEC score positive

76%

LRINEC score negative
34%
IVDU, intravenous drug user; LRINEC, laboratory risk indicator for
necrotizing fasciitis
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suspicion, and avoid the trap of using a “normal” LRINEC
score, in isolation, to dismiss the diagnosis. While a lower cutoff might improve the sensitivity, the accompanying cost to
specificity is not knowable in this study.
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